SCHEMBL30799237

SCHEMBL30799237

O=[N+]([O-])c1ccc(Cl)c2cc[nH]c12

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.48
ALDH1A1 P00352 3/20 0.45
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
VCAM1 P19320 8/20 0.41
FBP1 P09467 2/20 0.40
P2RX7 Q99572 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
DNA2 P51530 1/20 0.37
CASP6 P55212 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11003986 1.00 TDP1 (0.48) TDP1ALDH1A1TSHRMAPK1VCAM1
SCHEMBL3920360 0.86 TDP1 (0.48) TDP1ALDH1A1TSHRMAPK1VCAM1
Ethoxycarbonyl Group SCHEMBL28461257 0.84 TDP1 (0.36) TDP1ALDH1A1VCAM1FBP1P2RX7
SCHEMBL15845436 0.80 ALDH1A1 (0.43) TDP1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL31488147 0.79 ALDH1A1 (0.44) TDP1ALDH1A1TSHRMAPK1P2RX7
SCHEMBL2768608 0.79 ALDH1A1 (0.44) TDP1ALDH1A1TSHRMAPK1KDM4E
SCHEMBL22532255 0.79 CASP6 (0.50) TDP1ALDH1A1TSHRMAPK1VCAM1
SCHEMBL29764388 0.79 ALDH1A1 (0.44) TDP1ALDH1A1TSHRMAPK1KDM4E
SCHEMBL30799056 0.79 CASP6 (0.50) TDP1ALDH1A1TSHRMAPK1VCAM1
SCHEMBL6537811 0.78 TDP1 (0.44) TDP1ALDH1A1TSHRMAPK1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634155-A1 RBM39 SULFONAMIDE INHIBITORS Recursion Pharmaceuticals, Inc. (US) 2025-10-22 EP disclosed
EP-4573088-A1 HETEROCYCLE RBM39 MODULATORS Recursion Pharmaceuticals, Inc. (US) 2025-06-25 EP disclosed
WO-2024129634-A1 RBM39 SULFONAMIDE INHIBITORS RECURSION PHARMACEUTICALS, INC. (US) 2024-06-20 WO disclosed
WO-2024039689-A1 HETEROCYCLE RBM39 MODULATORS RECURSION PHARMACEUTICALS, INC. (US) 2024-02-22 WO disclosed